What are the guidelines for colorectal cancer screening?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Guidelines for Colorectal Cancer Screening

Clinicians should screen for colorectal cancer in average-risk adults starting at age 50 years and in high-risk adults starting at age 40 years or 10 years younger than the age at which the youngest affected relative was diagnosed with colorectal cancer. 1

Risk Assessment and Screening Initiation

  • All adults should undergo individualized risk assessment for colorectal cancer to determine appropriate screening age and method 1
  • Average-risk adults should begin screening at age 50 years 1
  • African Americans should begin screening at age 45 years due to higher disease burden 1, 2
  • High-risk individuals should begin screening at age 40 years or 10 years before the youngest affected relative's diagnosis, whichever comes first 1, 2
  • High-risk factors include:
    • First-degree relative with colorectal cancer or advanced adenoma diagnosed before age 60 1, 2
    • Two or more first-degree relatives with colorectal cancer or advanced adenoma 1
    • Personal history of inflammatory bowel disease (ulcerative colitis or Crohn's disease) 1
    • Hereditary syndromes such as Lynch syndrome (HNPCC) or familial adenomatous polyposis 1

Recommended Screening Methods

For Average-Risk Individuals

  • Stool-based tests:
    • Fecal immunochemical test (FIT) annually 1, 2
    • High-sensitivity guaiac-based fecal occult blood test (gFOBT) annually 1, 2
    • Multitarget stool DNA test (FIT-DNA) every 3 years 2
  • Structural examinations:
    • Colonoscopy every 10 years 1, 2
    • Flexible sigmoidoscopy every 5 years 1, 2
    • CT colonography every 5 years 1, 2
    • Double-contrast barium enema every 5 years 1

For High-Risk Individuals

  • Optical colonoscopy is the preferred screening method 1, 2
  • Screening intervals should be more frequent:
    • Every 5 years for those with family history of colorectal cancer 1
    • More frequent intervals for those with inflammatory bowel disease or hereditary syndromes 1

Selection of Screening Method

  • The choice of screening method should be based on:
    • Benefits and harms of the screening test 1
    • Availability of the screening test 1
    • Patient preferences and values 1, 2
  • All positive results from non-colonoscopy screening tests must be followed up with timely colonoscopy 2
  • The American College of Gastroenterology recommends colonoscopy as the preferred colorectal cancer prevention test 1

When to Stop Screening

  • Screening should be discontinued in adults over age 75 years 1, 2
  • Screening should be discontinued in adults with a life expectancy of less than 10 years 1, 3
  • For adults aged 76-85 years, screening decisions should be individualized based on:
    • Overall health status 2, 3
    • Prior screening history 2, 3
    • Life expectancy 2, 3

Important Considerations and Pitfalls

  • Quality of colonoscopy is critical for effective screening and should be monitored using quality indicators 2
  • Inadequate bowel preparation can reduce colonoscopy effectiveness 2
  • Failure to follow up positive stool-based tests with colonoscopy negates the benefit of screening 2
  • Recent evidence suggests increasing colorectal cancer incidence in younger adults, which has led some organizations to recommend starting screening at age 45 4, 5, 6
  • However, the American College of Physicians' most recent guidance (2023) recommends considering not screening asymptomatic average-risk adults between ages 45-49 years due to uncertainty around benefits and harms 7
  • Implementing screening at age 45 would add approximately 19 million people to the screening-eligible population 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.